Discover Your Future ...Today!

At each seminar, one or more keynote talks will be given by invited opinion leaders on subjects of high relevance to the biotechnology sector in the local region. Workshops will feature live demonstrations where our technical experts will explain key principles and guide you through the process of selecting the ideal solution to fit your requirements in the laboratory. Consideration will also be given to scaling-up of technologies.

Agenda

Keynote Talks

Subjects and speakers vary from venue to venue – please see the ‘Locations’ section below for further details

Cell Culture Session

Workshop A: ‘Sterile Filtration - Finding The Perfect Fit’
Discuss the challenges and demonstrate solutions for microbial control of cell culture or fermentation product during laboratory experiments, ranging from sterile to mycoplasma filtration.

Workshop B: ‘Bioreactors - Shaking Up Early-Stage Process Development’
This workshop will demonstrate a high-throughput screening technology for small-scale fermentation and cell culture experiments. Furthermore, ‘BLItz’ technology will demonstrate label-free protein analysis for drug discovery and bioprocess monitoring.

Purification And Separation Session, Part 1

Presentation: ‘High Throughput Screening Process Development Platform - A Powerful Approach to Accelerating Process Development and Purification’

Presentation: ‘Sorbent Capability Overview’

Lunch

Purification And Separation Session, Part 2

Workshop C: ‘Chromatography - Simplifying Complex Separations’
This workshop provides an overview of solutions to simplify purification of products using a wide range of chromatography columns (prepacked or non-prepacked) and membrane chromatography technologies in your laboratory and demonstrate the actual use of such a tool with a real-life example. It will also feature and discuss the tools available to scale up from laboratory scale to larger volume processes.

Workshop D: ‘Ultrafiltration - Quick and Efficient Separation of Biomolecules’
This workshop offers an overview of the principles of tangential flow filtration and compares two ultrafiltration techniques. It will feature a small-scale separation demonstration using centrifugal devices, followed by a demo with a tangential flow filtration system. Both these ultrafiltration methods enable the purification of biomolecules in an economic and efficient way.

Consult The Experts Session

Talk with Pall’s experts in one-to-one meetings. Choose from the following topics:

• Microbioreactors
• Sterile Filtration
• Chromatography
• Ultrafiltration and Concentration
• Single-Use Solutions
• Label-Free Protein Analysis

What The Particpants Are Saying….

• “Excellent speakers”
• “Competent, professional specialists!”
• “Good combination of theory and practice”
• “Organization was excellent and networking with other people was easy thanks to Pall”
• “Professional yet relaxed atmosphere”

Locations

Date	Country	Details	Keynote Speakers	Availability
3 May 2012	Italy	Milan	Dr. Sergio Dompé President, Dompé Farmaceutici Dr. Marco Ferrari Specialist in Health Management and Public Sector Law Dr. Marcello Fumagalli President, Chemical Pharmaceutical Generic Association, Italy Dr. Luca Romagnoli Molecular Medicine, Business Development Manager, Areta International	Event Completed
15 May 2012	Italy	Siena	Dr. Marco Ferrari Specialist in Health Management and Public Sector Law Dr. Marcello Fumagalli President, Chemical Pharmaceutical Generic Association, Italy Dr. Luca Romagnoli Molecular Medicine, Business Development Manager, Areta International	Event Completed
17 May 2012	Italy	Pomezia	Dr. Marco Ferrari Specialist in Health Management and Public Sector Law Dr. Marcello Fumagalli President, Chemical Pharmaceutical Generic Association, Italy Dr. Luca Romagnoli Molecular Medicine, Business Development Manager, Areta International	Event Completed
15 November 2012	Belgium	VWR International, Research Park Haasrode, Leuven	Dr. Philipe Ledent Head of Process Transfer and Development, Eurogentec ‘Implementing QbD From Discovery to Clinical Process Development’	Event Completed
14 February 2013	Netherlands	KennisCentrum, Leiden	Jeroen van Rheenen, Prosensa Therapeutics, 'Scale up of Oligonucleotides from Discovery to Clinical' Jolanda Geritsen, Genmab, 'Optimal selection of cell lines producing biopharmaceutical Human IgGs'	Event Completed
5 March 2013	UK	UCL, London	Tony Orchard, VP Global Marketing at Pall Life Sciences, 'If new biologics are the answer to healthcare and pharmaceutical industry challenges, what more might be done to improve the timeline and success rate of getting those products to market?'	Event Completed
12 March 2013	Germany	Munich, Martinsried	TBD	Event Completed
14 March 2013	Austria	Achensee	Univ. Prof. Dr. Christoph Herwig, Technische Universität Wien 'Forschungsbereich Bioverfahrenstechnik'	Event Completed
19 March 2013	France	Maison de la Recherche, Paris	Biotechnologies : quels enjeux pour ce secteur d'avenir ?', Mrs Arlette PETITJEAN, InterBiotech	Event Completed
21 March 2013	Austria	Vienna	Univ. Prof. Dr. Christoph Herwig, Technische Universität Wien 'Forschungsbereich Bioverfahrenstechnik'	Event Completed
28 March 2013	France	Château de Montchat, Lyon	Christian Siatka, Directeur Général, Ecole de l'ADN  'Les empreintes génétiques, de l'identification au fichage' Dr. Christian VALENTIN,Executive director R&D Bioprocess, Sanofi Pasteur, 'Concept du Quality by Design appliqué aux produits de biotechnologie'	Event Completed
4 April 2013	France	PullmanToulouse centre, Toulouse	Christian Siatka, Directeur Général, Ecole de l'ADN ,  'Les empreintes génétiques, de l'identification au fichage'	Event Completed
9 April 2013	France	Institut de Recherche Thérapeutique, Nantes	TBD	Event Completed
23 April 2013	Switzerland	Radisson Blu Hotel Basel, Basel	Peter Spies, Fachhochschule Nordwestschweiz FHNW, 'BLI - an outstanding technology for the determination of molecular recognition'	Register
25 April 2013	Switzerland	Grand Hotel Eden, Lugano	Peter Spies, Fachhochschule Nordwestschweiz FHNW, 'BLI - an outstanding technology for the determination of molecular recognition'	Register
30 April 2013	Czech Republic	TOP HOTEL Praha & Congress Centre, Prague	Prof. Christoph Herwig, Vienna University of Technology, Austria, 'Objectives and Procedures How to Decrease Time for Process Development'	Register
11 June 2013	Germany	Berlin	Univ. Prof. Dr. Christoph Herwig, Technische Universität Wien 'Forschungsbereich Bioverfahrenstechnik'	Register
13 June 2013	Germany	Dreieich	Dr. Philipe Ledent Head of Process Transfer and Development, Eurogentec, 'Implementing QbD From Discovery to Clinical Process Development'	Register
18 June 2013	Switzerland	Mövenpick Hotel, Lausanne	TBD	Register
20 June 2013	Switzerland	Cytos Biotechnology AG, Schlieren	TBD	Register
11 July 2013	Austria	CCB Biozentrum, Innsbruck	TBD	Register

Register for free
For more information please email DyF@pall.com

Note: If you would like to attend, but are unavailable on the specified date(s), please email us at the address above with your contact details and we will contact you.